Coexistence of Slipped Capital Femoral Epiphysis and multiple endocrine neoplasia type 2B (MEN2B) - a case report
DOI:
https://doi.org/10.12775/JEHS.2023.39.01.012Keywords
MEN2B, SCFE, Slipped Capital Femoral Epiphysis, Medullar Thyroid Cancer, MTC, Marfanoid habitusAbstract
Introduction: MEN 2B syndrome is distinguished by the occurrence of medullary thyroid cancer, pheochromocytoma, mucosal neuromas, marfanoid features, and skeletal anomalies, including kyphoscoliosis, joint laxity, pes cavus, and, in a smaller number of cases, slipped capital femoral epiphysis (SCFE).
Case report: We describe a case report of a 15-years-old patient with the diagnosis of the MEN2B syndrome with a rare manifestation of Slipped Capital Femoral Epiphysis (SCFE). A 15-year-old female presented to the orthopedics out-patient department (OPD) with complaints of pain around the right hip and knee and walking with a limp for approximately four months. Additionally, the feeling of enlarged thyroid gland was reported. X-ray confirmed the presence of the SCFE, while thyroid biopsy revealed the presence of medullary thyroid cancer (MTC). Thus, the diagnosis of MEN2B was made.
Conclusion: Slipped capital femoral epiphysis (SCFE) can occasionally be a manifestation of MEN 2B syndrome. It is important for physicians to be aware of this association, as it can contribute to the early detection of a potentially life-threatening condition.
References
Yasir M, Mulji NJ, Kasi A. Multiple Endocrine Neoplasias Type 2. [Updated 2022 Aug 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519054/
Walls GV. Multiple endocrine neoplasia (MEN) syndromes. Semin Pediatr Surg. 2014 Apr;23(2):96-101. doi: 10.1053/j.sempedsurg.2014.03.008. Epub 2014 Mar 15. PMID: 24931355.
Norton JA, Krampitz G, Jensen RT. Multiple Endocrine Neoplasia: Genetics and Clinical Management. Surg Oncol Clin N Am. 2015 Oct;24(4):795-832. doi: 10.1016/j.soc.2015.06.008. Epub 2015 Jul 27. PMID: 26363542; PMCID: PMC4571281.
Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P. Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol. 2021 Apr;17(4):207-224. doi: 10.1038/s41574-021-00468-3. Epub 2021 Feb 9. PMID: 33564173.
Yasir M, Mulji NJ, Kasi A. Multiple Endocrine Neoplasias Type 2. [Updated 2022 Aug 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519054/
Lee YJ, Liu HC, Lee HC, Tzen CY, Huang CY, Yang TL. Picture of the month. Multiple endocrine neoplasia 2B syndrome. Arch Pediatr Adolesc Med. 2001 Jul;155(7):845-6. doi: 10.1001/archpedi.155.7.845. PMID: 11434855.
Brauckhoff M, Gimm O. Extrathyroidal manifestations of multiple endocrine neoplasia type 2. Thyroid. 2009;19(6):555–557. http://doi.org/10.1089/thy.2009.0151
Lee YJ, Liu HC, Lee HC, Tzen CY, Huang CY, Yang TL. Picture of the month. Archives of Pediatrics and Adolescent Medicine. 2001;155(7):845–846.
. Znaczko A, Donnelly DE, Morrison PJ. Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population. Oncologist. 2014 Dec;19(12):1284-6. doi: 10.1634/theoncologist.2014-0277. Epub 2014 Oct 29. PMID: 25355845; PMCID: PMC4257749.
Alvandi E, Akrami SM, Chiani M, Hedayati M, Nayer BN, Tehrani MR, et al. Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population. Thyroid. 2011 Apr;21(4):373-82. doi: 10.1089/thy.2010.0267. PMID: 21309721.
Vasen HF, van der Feltz M, Raue F, Kruseman AN, Koppeschaar HP, Pieters G, et al. The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. Arch Intern Med. 1992 Jun;152(6):1250-2. PMID: 1350898.
Albores-Saavedra JA, Krueger JE. C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol. 2001 Winter;12(4):365-77. doi: 10.1385/ep:12:4:365. PMID: 11914470.
Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeney AT, Mueller PR, et al. Pheochromocytoma: an imaging chameleon. Radiographics. 2004 Oct;24 Suppl 1:S87-99. doi: 10.1148/rg.24si045506. PMID: 15486252.
Fink A, Lapidot M, Spierer A. Ocular manifestations in multiple endocrine neoplasia type 2b. Am J Ophthalmol. 1998 Aug;126(2):305-7. doi: 10.1016/s0002-9394(98)00102-0. PMID: 9727527.
Sallai A, Hosszú E, Gergics P, Rácz K, Fekete G. Orolabial signs are important clues for diagnosis of the rare endocrine syndrome MEN 2B. Presentation of two unrelated cases. Eur J Pediatr. 2008 Apr;167(4):441-6. doi: 10.1007/s00431-007-0532-x. Epub 2007 Jun 19. PMID: 17576593.
Alvandi E, Akrami SM, Chiani M, Hedayati M, Nayer BN, Tehrani MR, et al. Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population. Thyroid. 2011 Apr;21(4):373-82. doi: 10.1089/thy.2010.0267. PMID: 21309721.
Saltzman CL, Herzenberg JE, Phillips WA, Hensinger RN, Hopwood NJ. Thick lips, bumpy tongue, and slipped capital femoral epiphysis--a deadly combination. J Pediatr Orthop. 1988 Mar-Apr;8(2):219-22. PMID: 3350959.
Beukhof CM, van Biezen FC, de Herder WW. Slipped capital femoral epiphysis as manifestation of a rare endocrinological disease. Slipped capital femoral epiphysis. Neth J Med. 2011 Feb;69(2):84, 94. PMID: 21411848.
Brenkel IJ, Dias JJ, Davies TG, Iqbal SJ, Gregg PJ. Hormone status in patients with slipped capital femoral epiphysis. J Bone Joint Surg Br. 1989 Jan;71(1):33-8. doi: 10.1302/0301-620X.71B1.2521639. PMID: 2521639.
Witbreuk M, van Kemenade FJ, van der Sluijs JA, Jansma EP, Rotteveel J, van Royen BJ. Slipped capital femoral epiphysis and its association with endocrine, metabolic and chronic diseases: a systematic review of the literature. J Child Orthop. 2013 Jun;7(3):213-23. doi: 10.1007/s11832-013-0493-8. Epub 2013 Mar 30. PMID: 24432080; PMCID: PMC3672463.
Castinetti F, Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Sanso G, et al. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol. 2019 Mar;7(3):213-220. doi: 10.1016/S2213-8587(18)30336-X. Epub 2019 Jan 16. Erratum in: Lancet Diabetes Endocrinol. 2019 Mar;7(3):e3. PMID: 30660595; PMCID: PMC8132299.
Ball DW. Medullary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am. 2007 Sep;36(3):823-37, viii. doi: 10.1016/j.ecl.2007.04.001. PMID: 17673130; PMCID: PMC2806819.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Kamila Kędra, Maciej Bielak, Izabela Michalik, Julia Zarańska, Arkadiusz Aab, Karolina Bielak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 230
Number of citations: 0